Table II.
Multivariate regression model for CKD-EPI, including factors associated with reduced renal function in univariate analysis.
| Variables | β | B (SE) | P-value |
|---|---|---|---|
| Age (per year) | −0.42 | −0.67 (0.26) | 0.013 |
| ANGPTL2 (ln, ng/ml) | −0.29 | −7.7 (3.3) | 0.024 |
| sCD14 (ln, ng/ml) | −0.19 | −21.9 (12.9) | 0.095 |
| Framingham risk score (%) | 0.15 | 0.31 (0.29) | 0.29 |
| Antihypertensive therapy, yes | −0.03 | −1.1 (5.3) | 0.83 |
| Lipid-lowering drugs, yes | 0.002 | 0.11 (5.9) | 0.98 |
ANGPTL2, angiopoietin-like protein 2; β, standardized coefficient; B, unstandardized coefficient; sCD14, soluble CD14; SE, standard error.